Joana Goncalves
Equibles does not estimate personal net worth.
Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ORKA alertsAbout Joana Goncalves
Oruka Therapeutics, Inc. reported in an 8-K filed September 5, 2024 that Joana Goncalves was appointed Chief Medical Officer, effective August 29, 2024. Tvardi Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Joana Goncalves resigned as Chief Medical Officer, effective April 16, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $2,338,593 for Joana Goncalves in fiscal 2025, including a base salary of $474,000. Disclosed compensation is on record for 6 fiscal years. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.
“On August 29, 2024, the Board appointed Lawrence Klein as the Company’s President and Chief Executive Officer, Arjun Agarwal as the Company’s Senior Vice President, Finance and Treasurer, Joana Goncalves as the Company’s Chief Medical Officer and Paul Quinlan as General Counsel and Secretary, each to serve at the discretion of the Board.”
“On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the “Company”), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity.”
Affiliation history
-
Oruka Therapeutics, Inc. (ORKA)
Proxy statement
CurrentStart not stated–present
Last confirmed April 17, 2026
-
Tvardi Therapeutics, Inc. (TVRD)
Proxy statement
Start not stated–2024-04-16
Company network
Leadership on record at Oruka Therapeutics, Inc.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
- Carl Dambkowski Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | $474,000 | $2,338,593 |
| 2024 | Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | $155,854 | $317,986 |
| 2023 | Tvardi Therapeutics, Inc. (TVRD) | former Chief Medical Officer | $500,240 | $1,273,996 |
| 2022 | Tvardi Therapeutics, Inc. (TVRD) | former Chief Medical Officer | $481,000 | $1,550,355 |
| 2021 | Tvardi Therapeutics, Inc. (TVRD) | Chief Medical Officer | $465,000 | $1,736,943 |
| 2020 | Tvardi Therapeutics, Inc. (TVRD) | Chief Medical Officer | $451,200 | $1,338,702 |